Post Partum Hemorrhage Clinical Trial
Official title:
A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section
NCT number | NCT03891082 |
Other study ID # | 52 |
Secondary ID | |
Status | Not yet recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2019 |
Est. completion date | December 2019 |
Hundred (100) patients with primary postpartum hemorrhage during caesarean section due to
atonic uterus will be recruited for this study.and randomized to either B lynch or Bakeri
Ballon
B-Lynch:
A 70 mm round bodied hand needle on which a No. 2 absorbable suture is mounted is used to
puncture the uterus 3 cm from the right lower edge of the uterine incision and 3 cm from the
right lateral border. The mounted No. 2 absorbable suture is threaded through the uterine
cavity to emerge at the upper incision margin 3 cm above and approximately 4 cm from the
lateral border (because the uterus widens from below upwards). The absorbable suture now
visible is passed over to compress the uterine fundus approximately 34 cm from the right
cornual border. The absorbable suture is fed posteriorly and vertically to enter the
posterior wall of the uterine cavity at the same level as the upper anterior entry point. The
absorbable suture is pulled under moderate tension assisted by manual compression exerted by
the first assistant. The length of the absorbable suture is passed back posteriorly through
the same surface marking as for the right side, the suture lying horizontally. The absorbable
suture is fed through posteriorly and vertically over the fundus to lie anteriorly and
Research Template 7 Final Version: 1/6/2018 vertically compressing the fundus on the left
side as occurred on the right. The needle is passed in the same fashion on the left side
through the uterine cavity and out approximately 3 cm anteriorly and below the lower incision
margin on the left side. The two lengths of absorbable suture are pulled taught assisted by
bi-manual compression to minimize trauma and to achieve or aid compression. During such
compression the vagina is checked that the bleeding is controlled. As good hemostasis is
secured and whilst the uterus is compressed by an experienced assistant the principal surgeon
throws a knot (double throw) followed by two or three further throws to secure tension. The
lower transverse uterine incision is now closed in the normal way, in two layers, with or
without closure of the lower uterine segment peritoneum. BALLOON INSERTION Insert the balloon
portion of the catheter in the uterus; making certain that the entire balloon is inserted
past the cervical canal and internal ostium. NOTE: Avoid excessive force when inserting the
balloon into the uterus. Place a Foley catheter in patient bladder to collect and monitor
urine output. To ensure maintenance of correct placement and maximize tamponade effect, the
vaginal canal may be packed with iodine or antibiotic soaked vaginal gauze at this time.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 2019 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Patient undergoing caesarean sections landing up in atonic PPH during LSCS with failure of medical line of management: 1. Full term pregnancy 2. Didn't complete her family 3. Elective caesarian section Exclusion Criteria: - 1.) PPH after vaginal delivery 2.) Secondary PPH 3.) PPH due to causes other than atonicity 4.) Antepartum hemorrhage cases 5.) Patients with bleeding tendency 6.) If any complication occurred during caesarian section (e.g. bladder injury, DIC) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Estimation of blood loss: | number of saturated pads + amount in suction container (if used) + visualization by the operating team. | during the operation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03680339 -
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
|
Phase 4 | |
Completed |
NCT03693599 -
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
|
Phase 4 | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Recruiting |
NCT02306733 -
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
|
Phase 3 | |
Completed |
NCT01866241 -
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT01236482 -
Oxytocin in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Enrolling by invitation |
NCT06255496 -
QStat Cartridge in Obstetric Patients
|
||
Recruiting |
NCT04401839 -
Amr Maneuver for Prevention of Postpartum Hemorrhage
|
N/A | |
Recruiting |
NCT06219538 -
DAISY Uterine Drain Device Evaluation
|
N/A | |
Not yet recruiting |
NCT06333340 -
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
|
N/A | |
Completed |
NCT01863706 -
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
|
Phase 1 | |
Completed |
NCT04723979 -
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
|
||
Terminated |
NCT04277962 -
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
|
N/A | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT03117647 -
Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage
|
N/A | |
Active, not recruiting |
NCT03069859 -
Use of TXA to Prevent Postpartum Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT03463070 -
Misoprostol Before and After Cesarean Section
|
Phase 3 | |
Recruiting |
NCT05532215 -
Sublingual Misoprostol in Reduction of Caesarean Blood Loss
|
N/A | |
Completed |
NCT03907605 -
Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)
|